HomeCBIO • NASDAQ
add
Crescent Biopharma Inc
Previous close
$13.02
Day range
$13.03 - $14.01
Year range
$11.06 - $63.00
Market cap
185.33M USD
Avg Volume
84.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.22M | — |
Net income | -15.15M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.43M | — |
Total assets | 25.60M | — |
Total liabilities | 51.77M | — |
Total equity | -26.16M | — |
Shares outstanding | 7.05M | — |
Price to book | -3.04 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.15M | — |
Cash from operations | -10.85M | — |
Cash from investing | — | — |
Cash from financing | -1.49M | — |
Net change in cash | -12.34M | — |
Free cash flow | — | — |
About
Founded
2024
Headquarters
Website
Employees
4
